Company Filing History:
1 out of 167 
1 out of 822 
Years Active: 2018
Title: Ruxu Xu: Innovator in Pharmaceutical Chemistry
Introduction
Ruxu Xu is a notable inventor based in Tianjin, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on tricyclic quinoline and quinoxaline derivatives. His research focuses on the modulation of the 5-HT receptor, which plays a crucial role in various medical conditions.
Latest Patents
Ruxu Xu holds a patent for his invention titled "Tricyclic quinoline and quinoxaline derivatives." This patent relates to pharmaceutical compositions containing these compounds, which are used as modulators, specifically as agonists or partial agonists of the 5-HT receptor. The invention aims to provide methods for preventing or treating conditions and disorders that respond to the modulation of the 5-HT receptor.
Career Highlights
Throughout his career, Ruxu Xu has worked with prominent companies in the pharmaceutical industry, including AbbVie Deutschland GmbH & Co. KG and AbbVie Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas in drug development.
Collaborations
Ruxu Xu has collaborated with esteemed colleagues such as Hannes Koolman and Wilfried Martin Braje. These partnerships have contributed to the advancement of his research and the successful application of his inventions.
Conclusion
Ruxu Xu's work in pharmaceutical chemistry exemplifies the impact of innovation on medical science. His contributions, particularly in the area of 5-HT receptor modulation, highlight the importance of research and development in creating effective treatments for various health conditions.